companydata.dkNOVOZYMES BIOINDUSTRIAL CHINA A/S: Financial statements 2022
CVR: 21599042
NOVOZYMES BIOINDUSTRIAL CHINA A/S (CVR 21599042) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -1 and a net result of DKK 132,670,108 compared with DKK 56,066,583 the year before. Equity amounted to DKK 903,487,770. The solvency ratio was 98.7%.
- Gross Profit
- -1 kr.
- Profit/Loss
- 132,670,108 kr.
- Equity
- 903,487,770 kr.
- Total Assets
- 914,977,991 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -1 | 132.7 mio. | 903.5 mio. | 0 |
| 2021 | - | -33 t. | 56.1 mio. | 828.8 mio. | 0 |
| 2020 | - | -32 t. | 45.6 mio. | 817.8 mio. | 0 |
| 2019 | - | -38 t. | 283.5 mio. | 1.1 mia. | 0 |
| 2018 | - | -68 t. | -54 t. | 768.6 mio. | - |
Keep an eye on NOVOZYMES BIOINDUSTRIAL CHINA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2021. Gross profit came to DKK -33,035, and the net result was DKK 56,066,583.
About NOVOZYMES BIOINDUSTRIAL CHINA A/S
NOVOZYMES BIOINDUSTRIAL CHINA A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1999. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Lisbet Kragelund. The company is owned by NOVOZYMES A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 119,380,365 compared with DKK 394,633,084 the year before. Equity amounted to DKK 1,018,536,331.